Advancing Extrahepatic RNA Delivery Through Modular Peptide-Based Nanoparticles for Emerging Therapeutic Applications

8:45 am - Friday 19th February 2027

  • Enabling extrahepatic delivery to the tumour microenvironment using peptide-based nanoparticles
  • Optimising the modularity and flexibility of peptide-based delivery systems to improve tissue selectivity and expand targeting capabilities
  • Evaluating emerging oncology applications of non-viral delivery platforms, including preclinical approaches to assessing therapeutic performance and tissue distribution

Speakers:

Chief Operating Officer
Altamira Therapeutics